Zhengqing Group Solemnly Holds the 2026 Science and Technology Innovation Conference

From January 25 to January 27, Zhengqing Group grandly held its 2026 Science and Technology Innovation Conference in Huaihua. More than 70 core science and technology personnel and experts from the Group attended the conference, joined by Group leaders including Wu Feichi, Chairman and President of the Group; Huang Yuming, Vice Chairman; Xiang Weiguo, Chairman of the Board of Supervisors and Chairman of the Trade Union; and Long Xianjun, Rotating President.

The meeting invited the Municipal Science and Technology Bureau. Fourth-Level Research Officer Jiang Chengqi, Zhu Sheng, Deputy Director of the High‑Tech Zone Management Committee, and Zhengqing Group Liu Liang Professor Li Yanping, Deputy Director of the Academician and Expert Workstation; Professor Qiu Saihong, Chief Pharmacology Expert at the Liu Liang Academician and Expert Workstation of Zhengqing Group; Professor Yang Hua, Dean of the College of Biological Science and Technology at Hunan Agricultural University and Doctoral Supervisor; Professor Liu Jianxin, Dean of the School of Pharmacy at Hunan University of Chinese Medicine and Master’s Supervisor; Xu Wen, Assistant Researcher at the Huaihua Municipal Bureau of Agriculture and Rural Affairs; Associate Professor Xiao Yunhua, Lecturer at the College of Biological Science and Technology at Hunan Agricultural University and Master’s Supervisor; Zhang Shaonian, Head of the Key Project Department at Zhide and a Chinese Patent Attorney, along with other leading experts, attended the event together.

PART.01-02

Thematic Reports, Results Sharing, and Research Planning

Sharing of Typical Achievements

▲Dean Yang Hua Releases the Monograph “Resources and Utilization of Qingfeng Teng”

Annual Research Summary Plan

Exchange of Remarks

PART.3

Award Ceremony

In the third phase of the meeting, Chairman Xiang Weiguo of the Group’s Board of Supervisors and Chairman of the Trade Union took the lead in presiding. Xiang Weiguo first announced the 2025 Research Project and Achievement Award Program, with a total award amount of nearly 600,000 yuan.

In 2025, thanks to the concerted efforts of all scientific and technological personnel within the Group’s research system, the provincial major science and technology project—the Qingfeng Teng Full-Industry-Chain Project—successfully passed its acceptance inspection; the low-frequency ultrasound drug delivery device was approved for market launch; Zhengqing Fengtongning Sustained-Release Tablets entered the Macao market, with European registration work initiated concurrently last year; 46 research projects were fully underway, and a total of 13 projects successfully completed their final evaluations and acceptance throughout the year; 3 patents were granted, 8 patent applications (or filings) were submitted, and software copyright registration was completed for 5 items.

Zhu Sheng, Deputy Director of the High‑Tech Zone Management Committee, Jiang Chengqi, a Fourth‑Level Researcher at the Huaihua Municipal Science and Technology Bureau, along with Wu Feichi, Chairman and President of the Group; Huang Yuming, Vice Chairman; Long Xianjun, Rotating President; Yang Xiuchun, Assistant to the President; Qiu Qunying, Assistant to the President; Peng Yilin, Head of Finance; and Yin Songmao, Special Assistant to the President, presented awards to the winners in succession.

PART.4

Leadership Speech

The fourth session of the conference was chaired by Huang Yuming, Vice Chairman of the Group. He once again extended his congratulations to the researchers who received awards this time and encouraged everyone to delve deeper into the field of TCM research, continuously explore new frontiers, and strive to achieve even greater scientific breakthroughs.

All the experts unanimously agreed that technological innovation is the solid cornerstone of corporate development, laying a robust technological foundation for the high‑quality growth of Zhengqing Group. The outstanding performance of Zhengqing’s research team at this Technology Innovation Conference fully showcased the company’s profound technological heritage and its cutting‑edge R&D capabilities.

In her speech, Zhu Sheng stated that in 2025, Zhengqing Group delivered an impressive performance in its development, particularly with sustained efforts and fruitful results in the field of scientific research and innovation, which are worthy of recognition. She expressed the hope that Zhengqing Group would fully leverage its role as a model and leader in science and technology innovation, actively sharing and exchanging its valuable experience in building a robust research team system with other enterprises within the park, thereby driving the park’s overall level of scientific and technological innovation to a new height. At the same time, she pledged that, as a science and technology management professional, she would diligently perform her service and management duties, working hand in hand with all parties to contribute to the high‑quality development of science and technology innovation in Huaihua.

In his guiding remarks, Jiang Chengqi highly commended the achievements that Zhengqing Group has made in 2025, as well as the dedication and professional competence of the experts and research teams in attendance. He expressed the hope that Zhengqing would proactively assume responsibility and help drive the high‑quality, large‑scale development of the traditional Chinese medicine industry in Huaihua. The science and technology authorities will integrate resources to ensure the smooth operation of the Provincial Modern Chinese Medicine Pharmaceutical Process Technology Innovation Center and strive to elevate it to a national-level institution, while providing robust support services to foster enterprise innovation, secure necessary resources, and work hand in hand to promote regional industrial prosperity.